The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence

Trends in Microbiology

Volumn 10, Issue 11, 2002, Pages 515-521

  Banks, David J ^a   Beres, Stephen B ^a   Musser, James M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; VIRULENCE FACTOR;

BACTERIAL STRAIN; DISEASE SEVERITY; EVOLUTION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOMICS; GEOGRAPHY; GLOMERULONEPHRITIS; IMPETIGO; MORBIDITY; MYOSITIS; NECROTIZING FASCIITIS; NONHUMAN; PHARYNGITIS; PRIORITY JOURNAL; PROPHAGE; REGULATORY MECHANISM; REVIEW; RHEUMATIC FEVER; SCARLET FEVER; SEPTIC SHOCK; SEROTYPE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TONSILLITIS;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION, VIRAL; GENOME, BACTERIAL; LYSOGENY; MACROLIDES; STREPTOCOCCUS PHAGES; STREPTOCOCCUS PYOGENES; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS SP. 'GROUP A';

EID: 0036842339     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(02)02461-7     Document Type: Review

References (54)

1. Musser J.M., Krause R.M. The revival of group A streptococcal diseases, with a commentary on staphylococcal toxic shock syndrome. Krause R.M., Emerging Infections. 1998;185-218 Academic Press.
2. Sharkawy A., et al. Severe group A streptococcal soft tissue infections in Ontario: 1992-1996. Clin. Infect. Dis. 34:2002;454-460.
3. O'Brien K.L., et al. Epidemiology of invasive Group A Streptococcus disease in the United States, 1995-1999. Clin. Infect. Dis. 35:2002;268-276.
4. Ferretti J.J., et al. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc. Natl. Acad. Sci. U. S. A. 98:2001;4658-4663.
5. Smoot J.C., et al. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc. Natl. Acad. Sci. U. S. A. 99:2002;4668-4673.
6. Beres S.B., et al. Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc. Natl. Acad. Sci. U. S. A. 99:2002;10078-10083.
7. Fitzgerald J.R., Musser J.M. Evolutionary genomics of pathogenic bacteria. Trends Microbiol. 9:2001;547-553.
8. Cunningham M.W. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:2000;470-511.
9. Leung D.Y.M., et al. Superantigens: Molecular Biology, Immunology and Relevance to Human Disease. 1997;M. Dekker.
10. Llewelyn M., Cohen J. Superantigens: microbial agents that corrupt immunity. Lancet Infect. Dis. 2:2002;156-162.
11. Sriskandan S., et al. Mitogenic factor (MF) is the major DNase of serotype M89 Streptococcus pyogenes. Microbiology. 146:2000;2785-2792.
12. Gerlach D., et al. Basic streptococcal superantigens (SPEX/SMEZ or SPEC) are responsible for the mitogenic activity of the so-called mitogenic factor (MF). FEMS Immunol. Med. Microbiol. 30:2001;209-216.
13. Broudy T.B., et al. The in vitro interaction of Streptococcus pyogenes with human pharyngeal cells induces a phage-encoded extracellular Dnase. Infect. Immun. 70:2002;2805-2811.
14. Halperin S.A., et al. Antibody response to bacteriophage hyaluronidase in acute glomerulonephritis after group A Streptococcal infection. J. Infect. Dis. 155:1987;253-261.
15. Kamezawa Y., et al. Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes. Infect. Immun. 65:1997;3828-3833.
16. Proft T., et al. Identification and characterization of novel superantigens from Streptococcus pyogenes. J. Exp. Med. 189:1999;89-101.
17. Johnson L.P., Schlievert P.M. Group A streptococcal phage T12 carries the structural gene for pyrogenic exotoxin type A. Mol. Gen. Genet. 194:1984;52-56.
18. Goshorn S.C., et al. Cloning and characterization of the gene, speC, for pyrogenic exotoxin type C from Streptococcus pyogenes. Mol. Gen. Genet. 212:1988;66-70.
19. Nelson K., et al. Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes. J. Exp. Med. 174:1991;1271-1274.
20. Musser J.M., et al. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (scarlet fever toxin). J. Infect. Dis. 167:1993;337-346.
21. Kline J.B., Collins C.M. Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A. Infect. Immun. 64:1996;2122-2129.
22. Ikebe T., et al. Dissemination of the phage-associated novel superantigen gene speL in recent invasive and noninvasive M3/T3 Streptococcus pyogenes isolates in Japan. Infect. Immun. 70:2002;3227-3233.
23. Stevens D., et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321:1989;1-7.
24. Musser J.M., et al. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc. Natl. Acad. Sci. U. S. A. 88:1991;2668-2672.
25. Schwartz B., et al. Changing epidemiology of group A streptococcal infection in the USA. Lancet. 336:1990;1167-1171.
26. Desiere F., et al. Comparative genomics reveals close genetic relationships between phages from dairy bacteria and pathogenic streptococci: evolutionary implications for prophage-host interactions. Virology. 288:2001;325-341.
27. Colon A.E., et al. Lysis and lysogenization of groups A, C, and G streptococci by a transducing bacteriophage induced from a group G Streptococcus. J. Virol. 8:1971;103-110.
28. Artiushin S.C., et al. Characterization and immunity of pyrogenic mitogens SePE-H and SePE-I of Streptococcus equi. Microb. Pathog. 32:2002;71-85.
29. Botstein D. A theory of modular evolution for bacteriophages. Ann. New York Acad. Sci. 354:1980;484-490.
30. Veasy L.G., et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N. Engl. J. Med. 316:1987;421-427.
31. Smoot J.C., et al. Molecular analysis of group A Streptococcus type emm18 isolates temporally associated with acute rheumatic fever outbreaks in Salt Lake City, Utah. J. Clin. Microbiol. 40:2002;1805-1810.
32. Seppala H., et al. Resistance to erythromycin in group A streptococci. N. Engl. J. Med. 326:1992;292-297.
33. Kataja J., et al. Erythromycin resistance genes in group A streptococci of different geographical origins. J. Antimicrob. Chemother. 46:2000;789-792.
34. Martin J.M., et al. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N. Engl. J. Med. 346:2002;1200-1206.
35. Hsueh P., et al. Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan. Microb. Drug Resist. 8:2002;27-33.
36. Espinosa de los Monteros L.E., et al. Outbreak of scarlet fever caused by an erythromycin-resistant Streptococcus pyogenes emm22 genotype strain in a day-care center. Pediatr. Infect. Dis. J. 20:2001;807-809.
37. Facinelli B., et al. Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci. Lancet. 358:2001;30-33.
38. LeClercq R., Courvalin P. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35:1991;1267-1272.
39. Bingen E., et al. Emergence of group A Streptococcus strains with different mechanisms of macrolide resistance. Antimicrob. Agents Chemother. 46:2002;1199-1203.
40. Clancy J., et al. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol. Microbiol. 22:1996;867-879.
41. Sutcliffe J., et al. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1996;1817-1824.
42. Malke H., Kohler W. Transduction among group A streptococci: transducibility of strains representative of thirty different M types. Zbl. Bakt. Hyg. I. Abt. Orig. A. 224:1973;194-201.
43. Malke H. Genetics of resistance to macrolide antibiotics and lincomycin in natural isolates of Streptococcus pyogenes. Mol. Gen. Genet. 135:1974;349-367.
44. Malke H., et al. Bacteriophage P13234mo-mediated intra- and intergroup transduction of antibiotic resistance among streptococci. Zbl. Bakt. Hyg. I. Abt. Orig. A. 233:1975;24-34.
45. Ubukata K., et al. Transduction of drug resistance to tetracycline, chloramphenicol, macrolides, lincomycin and clindamycin with phages induced from Streptococcus pyogenes. J. Antibiot. (Tokyo). 28:1975;681-688.
46. Hyder S.L., Streitfeld M.M. Transfer of erythromycin resistance from clinically isolated lysogenic strains of Streptococcus pyogenes. J. Infect. Dis. 138:1978;281-286.
47. McShan W.M. The bacteriophages of group A streptococci. Fischetti V.A., et al. Gram-Positive Pathogens. 2000;105-116 ASM Press.
48. McIver K.S., Scott J.R. Role of mga in growth phase regulation of virulence genes of the group A Streptococcus. J. Bacteriol. 179:1997;5178-5187.
49. Federle M.J., et al. A response regulator that represses transcription of several virulence operons in the group A. Streptococcus. J. Bacteriol. 181:1999;3649-3657.
50. Smoot L.M., et al. Global differential gene expression in response to growth temperature alteration in group A Streptococcus. Proc. Natl. Acad. Sci. U. S. A. 98:2001;10416-10421.
51. Broudy T.B., et al. Induction of lysogenic bacteriophage and phage-associated toxin from group A streptococci during coculture with human pharyngeal cells. Infect. Immun. 69:2001;1440-1443.
52. Kazmi S.U., et al. Reciprocal, temporal expression of SpeA and SpeB by invasive M1T1 group A streptococcal isolates in vivo. Infect. Immun. 69:2001;4988-4995.
53. Ohnishi M., et al. Diversification of Escherichia coli genomes: are bacteriophages the major contributors? Trends Microbiol. 9:2001;481-485.
54. Chetouani F., et al. FindTarget: software for subtractive genome analysis. Microbiology. 147:2001;2643-2649.